Review





Similar Products

90
Abbott Laboratories ™ nicquick™ nicotine/cotinine test
™ Nicquick™ Nicotine/Cotinine Test, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nicotine+and+cotinine/++nicquick++nicotine+cotinine+test/med_rxiv__2024__10__10__24315204-51-19-22
Average 90 stars, based on 1 article reviews
™ nicquick™ nicotine/cotinine test - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Siemens Healthineers immulite 2000 nicotine metabolite (cotinine) 600 test
Immulite 2000 Nicotine Metabolite (Cotinine) 600 Test, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nicotine+and+cotinine/immulite+1000+nicotine+metabolite+kit/pmc11116423__43856_2024_513_MOESM2_ESM-278-9-22
Average 90 stars, based on 1 article reviews
immulite 2000 nicotine metabolite (cotinine) 600 test - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Toronto Research Chemicals deuterated internal standard solution nicotine-d3 and cotinine-d3
Deuterated Internal Standard Solution Nicotine D3 And Cotinine D3, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nicotine+and+cotinine/nicotine+d3/pm38513068-54-27-28
Average 90 stars, based on 1 article reviews
deuterated internal standard solution nicotine-d3 and cotinine-d3 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Toronto Research Chemicals deuterated internal standard solution containing nicotine-d3 and cotinine-d3
Time-course changes of blood nicotine (A) and <t>cotinine</t> (B) levels following acute injections of methoxsalen (15 & 30 mg/kg, i.p.) and nicotine (0.5 mg/kg, s.c.) in rats. Methoxsalen was injected 30 min prior to the nicotine injection. # p < 0.05, significantly different from the methoxsalen treatments.
Deuterated Internal Standard Solution Containing Nicotine D3 And Cotinine D3, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nicotine+and+cotinine/nicotine+d3/bio_rxiv__2023__06__04__543614-63-13-14
Average 90 stars, based on 1 article reviews
deuterated internal standard solution containing nicotine-d3 and cotinine-d3 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Lipomed analytical standards nicotine and cotinine
Time-course changes of blood nicotine (A) and <t>cotinine</t> (B) levels following acute injections of methoxsalen (15 & 30 mg/kg, i.p.) and nicotine (0.5 mg/kg, s.c.) in rats. Methoxsalen was injected 30 min prior to the nicotine injection. # p < 0.05, significantly different from the methoxsalen treatments.
Analytical Standards Nicotine And Cotinine, supplied by Lipomed, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nicotine+and+cotinine/analytical+standards+nicotine+and+cotinine/pm36838551-251-7-11
Average 90 stars, based on 1 article reviews
analytical standards nicotine and cotinine - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Dr Ehrenstorfer GmbH nicotine and cotinine standards
Time-course changes of blood nicotine (A) and <t>cotinine</t> (B) levels following acute injections of methoxsalen (15 & 30 mg/kg, i.p.) and nicotine (0.5 mg/kg, s.c.) in rats. Methoxsalen was injected 30 min prior to the nicotine injection. # p < 0.05, significantly different from the methoxsalen treatments.
Nicotine And Cotinine Standards, supplied by Dr Ehrenstorfer GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nicotine+and+cotinine/nicotine+and+cotinine+standards/pmc09892440-50-0-7
Average 90 stars, based on 1 article reviews
nicotine and cotinine standards - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
WIL Research nicotine and cotinine concentrations
Time-course changes of blood nicotine (A) and <t>cotinine</t> (B) levels following acute injections of methoxsalen (15 & 30 mg/kg, i.p.) and nicotine (0.5 mg/kg, s.c.) in rats. Methoxsalen was injected 30 min prior to the nicotine injection. # p < 0.05, significantly different from the methoxsalen treatments.
Nicotine And Cotinine Concentrations, supplied by WIL Research, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nicotine+and+cotinine/nicotine+and+cotinine+concentrations/pm36336278-70-6-14
Average 90 stars, based on 1 article reviews
nicotine and cotinine concentrations - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
NMS Labs nicotine and cotinine
Time-course changes of blood nicotine (A) and <t>cotinine</t> (B) levels following acute injections of methoxsalen (15 & 30 mg/kg, i.p.) and nicotine (0.5 mg/kg, s.c.) in rats. Methoxsalen was injected 30 min prior to the nicotine injection. # p < 0.05, significantly different from the methoxsalen treatments.
Nicotine And Cotinine, supplied by NMS Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nicotine+and+cotinine/nicotine+and+cotinine/pm36395323-81-2-9
Average 90 stars, based on 1 article reviews
nicotine and cotinine - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
LabCorp nicotine/cotinine, screen and confirmation, urine
Time-course changes of blood nicotine (A) and <t>cotinine</t> (B) levels following acute injections of methoxsalen (15 & 30 mg/kg, i.p.) and nicotine (0.5 mg/kg, s.c.) in rats. Methoxsalen was injected 30 min prior to the nicotine injection. # p < 0.05, significantly different from the methoxsalen treatments.
Nicotine/Cotinine, Screen And Confirmation, Urine, supplied by LabCorp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nicotine+and+cotinine/cotinine+assay/10__5858_slash_arpa__2022___0094___cp-304-4-6
Average 90 stars, based on 1 article reviews
nicotine/cotinine, screen and confirmation, urine - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Metabolon Inc nicotine metabolite cotinine
Time-course changes of blood nicotine (A) and <t>cotinine</t> (B) levels following acute injections of methoxsalen (15 & 30 mg/kg, i.p.) and nicotine (0.5 mg/kg, s.c.) in rats. Methoxsalen was injected 30 min prior to the nicotine injection. # p < 0.05, significantly different from the methoxsalen treatments.
Nicotine Metabolite Cotinine, supplied by Metabolon Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nicotine+and+cotinine/nicotine+metabolite+cotinine/pmc09502737-93-14-24
Average 90 stars, based on 1 article reviews
nicotine metabolite cotinine - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Time-course changes of blood nicotine (A) and cotinine (B) levels following acute injections of methoxsalen (15 & 30 mg/kg, i.p.) and nicotine (0.5 mg/kg, s.c.) in rats. Methoxsalen was injected 30 min prior to the nicotine injection. # p < 0.05, significantly different from the methoxsalen treatments.

Journal: bioRxiv

Article Title: Methoxsalen inhibited the acquisition of nicotine self-administration: attenuation by cotinine replacement in rats

doi: 10.1101/2023.06.04.543614

Figure Lengend Snippet: Time-course changes of blood nicotine (A) and cotinine (B) levels following acute injections of methoxsalen (15 & 30 mg/kg, i.p.) and nicotine (0.5 mg/kg, s.c.) in rats. Methoxsalen was injected 30 min prior to the nicotine injection. # p < 0.05, significantly different from the methoxsalen treatments.

Article Snippet: Briefly, plasma samples were spiked with deuterated internal standard solution containing nicotine-d3 and cotinine-d3 (Toronto Research Chemicals Inc, Toronto, CA) and acetonitrile/methanol (50/50) solvent.

Techniques: Injection

Effects of vehicle and methoxsalen on the acquisition of nicotine self-administration in rats. Methoxsalen (15 mg/kg, i.p.) or vehicle was injected 30 minutes prior to the start of each session. A: Number of infusions per session across treated and untreated sessions. * p < 0.05, significantly lower in the methoxsalen-treated group. B & C: Number of responses on active and inactive levers in the vehicle-treated (B) and methoxsalen-treated (C) groups #, p < 0.05, significantly greater for active responses. D: Total nicotine intake during the first 10 acquisition sessions. * p < 0.05, significantly lower in the methoxsalen-treated group. E: Plasma nicotine and cotinine levels following the 10 th acquisition session. * p < 0.05, significantly lower in the methoxsalen-treated group.

Journal: bioRxiv

Article Title: Methoxsalen inhibited the acquisition of nicotine self-administration: attenuation by cotinine replacement in rats

doi: 10.1101/2023.06.04.543614

Figure Lengend Snippet: Effects of vehicle and methoxsalen on the acquisition of nicotine self-administration in rats. Methoxsalen (15 mg/kg, i.p.) or vehicle was injected 30 minutes prior to the start of each session. A: Number of infusions per session across treated and untreated sessions. * p < 0.05, significantly lower in the methoxsalen-treated group. B & C: Number of responses on active and inactive levers in the vehicle-treated (B) and methoxsalen-treated (C) groups #, p < 0.05, significantly greater for active responses. D: Total nicotine intake during the first 10 acquisition sessions. * p < 0.05, significantly lower in the methoxsalen-treated group. E: Plasma nicotine and cotinine levels following the 10 th acquisition session. * p < 0.05, significantly lower in the methoxsalen-treated group.

Article Snippet: Briefly, plasma samples were spiked with deuterated internal standard solution containing nicotine-d3 and cotinine-d3 (Toronto Research Chemicals Inc, Toronto, CA) and acetonitrile/methanol (50/50) solvent.

Techniques: Injection

Effects of methoxsalen and vehicle on the maintenance of nicotine self-administration in rats. Methoxsalen (15 & 30 mg/kg, i.p.) or vehicle were injected 30 minutes prior to the start of each session. A: Number of infusions per session. B & C: Number of active and inactive responses in the vehicle-treated (B) and methoxsalen-treated (C) group. #, p < 0.05, significantly greater for active responses. D: Total nicotine intake across all sessions. E: Plasma nicotine and cotinine levels following the last session treated with 15 mg/kg methoxsalen. * p < 0.05, significantly lower in the methoxsalen-treated group.

Journal: bioRxiv

Article Title: Methoxsalen inhibited the acquisition of nicotine self-administration: attenuation by cotinine replacement in rats

doi: 10.1101/2023.06.04.543614

Figure Lengend Snippet: Effects of methoxsalen and vehicle on the maintenance of nicotine self-administration in rats. Methoxsalen (15 & 30 mg/kg, i.p.) or vehicle were injected 30 minutes prior to the start of each session. A: Number of infusions per session. B & C: Number of active and inactive responses in the vehicle-treated (B) and methoxsalen-treated (C) group. #, p < 0.05, significantly greater for active responses. D: Total nicotine intake across all sessions. E: Plasma nicotine and cotinine levels following the last session treated with 15 mg/kg methoxsalen. * p < 0.05, significantly lower in the methoxsalen-treated group.

Article Snippet: Briefly, plasma samples were spiked with deuterated internal standard solution containing nicotine-d3 and cotinine-d3 (Toronto Research Chemicals Inc, Toronto, CA) and acetonitrile/methanol (50/50) solvent.

Techniques: Injection

Effects of mixing cotinine (0.00375-0.03 mg/kg/infusion) and nicotine (0.03 mg/kg/infusion) on methoxsalen-inhibited nicotine self-administration in rats. Methoxsalen (15 mg/kg, i.p.) was injected 30 minutes prior to the start of each session. A: Number of infusions per session. * p < 0.05, significantly greater than the ‘NIC0.03+COT0.00375’ group. B: Total intake of nicotine and cotinine during the acquisition stage. * p < 0.05, significantly greater than the ‘NIC0.03+COT0.00375’ group. # p < 0.05, significantly greater than the ‘NIC0.03+COT0.00375’ and ‘NIC0.03+COT0.0075’ groups. $ p < 0.05, significantly greater than any other groups. C: Plasma nicotine and cotinine levels after the 10 th acquisition session. # p < 0.05, significantly greater than ‘NIC0.03+COT0.00375’ and ‘NIC0.03+COT0.0075’ groups. $ p < 0.05, significantly greater than any other groups. D: Total intake of nicotine and cotinine during the maintenance stage. # p < 0.05, significantly greater than ‘NIC0.03+COT0.00375’ and ‘NIC0.03+COT0.0075’ groups. $ p < 0.05, significantly greater than any other groups. E: Plasma nicotine and cotinine levels after the 10 th acquisition session. * p < 0.05, significantly greater than the ‘NIC0.03+COT0.00375’ group. $ p < 0.05, significantly greater than any other groups.

Journal: bioRxiv

Article Title: Methoxsalen inhibited the acquisition of nicotine self-administration: attenuation by cotinine replacement in rats

doi: 10.1101/2023.06.04.543614

Figure Lengend Snippet: Effects of mixing cotinine (0.00375-0.03 mg/kg/infusion) and nicotine (0.03 mg/kg/infusion) on methoxsalen-inhibited nicotine self-administration in rats. Methoxsalen (15 mg/kg, i.p.) was injected 30 minutes prior to the start of each session. A: Number of infusions per session. * p < 0.05, significantly greater than the ‘NIC0.03+COT0.00375’ group. B: Total intake of nicotine and cotinine during the acquisition stage. * p < 0.05, significantly greater than the ‘NIC0.03+COT0.00375’ group. # p < 0.05, significantly greater than the ‘NIC0.03+COT0.00375’ and ‘NIC0.03+COT0.0075’ groups. $ p < 0.05, significantly greater than any other groups. C: Plasma nicotine and cotinine levels after the 10 th acquisition session. # p < 0.05, significantly greater than ‘NIC0.03+COT0.00375’ and ‘NIC0.03+COT0.0075’ groups. $ p < 0.05, significantly greater than any other groups. D: Total intake of nicotine and cotinine during the maintenance stage. # p < 0.05, significantly greater than ‘NIC0.03+COT0.00375’ and ‘NIC0.03+COT0.0075’ groups. $ p < 0.05, significantly greater than any other groups. E: Plasma nicotine and cotinine levels after the 10 th acquisition session. * p < 0.05, significantly greater than the ‘NIC0.03+COT0.00375’ group. $ p < 0.05, significantly greater than any other groups.

Article Snippet: Briefly, plasma samples were spiked with deuterated internal standard solution containing nicotine-d3 and cotinine-d3 (Toronto Research Chemicals Inc, Toronto, CA) and acetonitrile/methanol (50/50) solvent.

Techniques: Injection